MISTY SIMPSON: Open Payments
NPI 1538311741 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 54 payments from 13 companies in 2025. Trend: 2023 $2,040 · 2024 $975 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $173 |
| PFIZER INC. | 8 | $146 |
| E.R. Squibb & Sons, L.L.C. | 9 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Boston Scientific Corporation | 2 | $45 |
| Philips North America LLC | 2 | $35 |
| Medtronic, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: REPATHA, ELIQUIS, LEQVIO, CAMZYOS, Kerendia, WATCHMAN FLX, VYNDAQEL, FARXIGA.
Industry payments across TX — which companies pay providers there.
